Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Invested Capital (2016 - 2025)

Historic Invested Capital for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $105.3 billion.

  • Sanofi's Invested Capital rose 479.04% to $105.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $105.3 billion, marking a year-over-year increase of 479.04%. This contributed to the annual value of $102.2 billion for FY2025, which is 43.4% up from last year.
  • Latest data reveals that Sanofi reported Invested Capital of $105.3 billion as of Q4 2025, which was up 479.04% from $87.8 billion recorded in Q2 2025.
  • Sanofi's Invested Capital's 5-year high stood at $105.3 billion during Q4 2025, with a 5-year trough of $5.7 billion in Q2 2021.
  • Over the past 5 years, Sanofi's median Invested Capital value was $92.2 billion (recorded in 2022), while the average stood at $84.7 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 9223.21% in 2021, then surged by 128811.06% in 2022.
  • Sanofi's Invested Capital (Quarter) stood at $101.7 billion in 2021, then decreased by 5.73% to $95.9 billion in 2022, then grew by 1.96% to $97.8 billion in 2023, then increased by 2.72% to $100.4 billion in 2024, then grew by 4.79% to $105.3 billion in 2025.
  • Its Invested Capital stands at $105.3 billion for Q4 2025, versus $87.8 billion for Q2 2025 and $100.4 billion for Q4 2024.